Eribulin Mesylate Injection
Product Images NDC 0781-3391

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 0781-3391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical_structure (Eribulin 01)

Chemical structure of eribulin mesylate, the active ingredient in Eribulin Mesylate injection, 0.5 mg/mL, by Sandoz Inc. The diagram shows the molecular arrangement including multiple cyclic structures, oxygen atoms, hydrogen atoms, and a methanesulfonic acid component.*

FDA Label Image

Figure-1 (Eribulin 02)

A Kaplan-Meier survival curve chart comparing the proportion of patients alive over time (in months) for Eribulin Mesylate (N=508) and a control group (N=254). The chart shows survival probability declining over a 36-month period, with Eribulin Mesylate patients demonstrating higher survival probability compared to control patients at most time points. Patient numbers at risk are indicated below the time axis.*

FDA Label Image

Figure-2 (Eribulin 03)

A survival curve chart comparing the survival probability over time (months) for patients treated with Eribulin Mesylate versus Dacarbazine. The solid line represents Eribulin Mesylate and the dashed line represents Dacarbazine, with the number of subjects at risk listed below the x-axis at various time points.*

FDA Label Image

Carton (Eribulin 04)

Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use, labeled by Sandoz Inc. The label includes instructions for use, storage conditions, and a caution for cytotoxicity. It specifies a single-dose vial with directions to discard unused portions and has manufacturer information listing Kindos Pharmaceuticals Co., Ltd. for Sandoz Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.